![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Active Filter(s):
Details:
Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections and zero fingersticks.
Lead Product(s): Insulin
Therapeutic Area: Endocrinology Product Name: Omnipod
Highest Development Status: Approved Product Type: Peptide
Recipient: Bigfoot Biomedical
Deal Size: $25.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition February 13, 2023